Non-HDL Cholesterol: A New Endpoint in Cardio-Metabolic Health Monitoring

Por Baker, Ross A., Forbes, Robert A.
Publicado em 2010

Trends in Combination Antipsychotic Use Among Persons With Commercial Insurance: A Data Snapshot

Por Citrome, Leslie, Guo, Zhenchao, Kalsekar, Iftekhar, Forbes, Robert A., Hebden, Tony
Publicado em 2012

Medical Care Costs and Hospitalization in Patients with Bipolar Disorder Treated with Atypical Antipsychotics

Por Bergeson, Joette Gdovin, Kalsekar, Iftekhar, Jing, Yonghua, You, Min, Forbes, Robert A., Hebden, Tony
Publicado em 2012

Efficacy of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Response Quartile Analysis and the Predictive Value of Week 2 Early Response

Por Casey, Daniel E., Laubmeier, Kimberly K., Marler, Sabrina Vogel, Forbes, Robert A., Baker, Ross A.
Publicado em 2012

Aripiprazole Treatment of Irritability Associated with Autistic Disorder and the Relationship Between Prior Antipsychotic Exposure, Adverse Events, and Weight Change

Por Mankoski, Raymond, Stockton, Gwen, Manos, George, Marler, Sabrina, McQuade, Robert, Forbes, Robert A., Marcus, Ronald
Publicado em 2013

Beneficial Effects of Adjunctive Aripiprazole in Major Depressive Disorder Are Not Dependent on Antidepressant Therapy History: A Post Hoc Analysis of 3 Randomized, Double-Blind, P...

Por Dunner, David L., Laubmeier, Kimberly K., Manos, George, Forbes, Robert A., Baker, Ross A., Berman, Robert M.
Publicado em 2012

A 52-Week, Double-Blind Evaluation of the Metabolic Effects of Aripiprazole and Lithium in Bipolar I Disorder

Por McIntyre, Roger S., McElroy, Susan L., Eudicone, James M., Forbes, Robert A., Carlson, Berit X., Baker, Ross A.
Publicado em 2011

Clinical Significance of Treatment Effects with Aripiprazole versus Placebo in a Study of Manic or Mixed Episodes Associated with Pediatric Bipolar I Disorder

Por Youngstrom, Eric, Zhao, Joan, Mankoski, Raymond, Forbes, Robert A., Marcus, Ronald M., Carson, William, McQuade, Robert, Findling, Robert L.
Publicado em 2013

Effects of Adjunctive Aripiprazole on Sexual Functioning in Patients With Major Depressive Disorder and an Inadequate Response to Standard Antidepressant Monotherapy: A Post Hoc An...

Por Fava, Maurizio, Dording, Christina M., Baker, Ross A., Mankoski, Raymond, Tran, Quynh-Van, Forbes, Robert A., Eudicone, James M., Owen, Randall, Berman, Robert M.
Publicado em 2011

Improvement in Functional Outcomes With Adjunctive Aripiprazole Versus Placebo in Major Depressive Disorder: A Pooled Post Hoc Analysis of 3 Short-Term Studies

Por Fabian, Tanya J., Cain, Zachary J., Ammerman, Diane, Eudicone, James M., Tang, Yan, Rollin, Linda M., Forbes, Robert A., Berman, Robert M., Baker, Ross A.
Publicado em 2012

Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis()

Por Steffens, David C., Nelson, J. Craig, Eudicone, James M., Andersson, Candace, Yang, Huyuan, Tran, Quynh-Van, Forbes, Robert A., Carlson, Berit X., Berman, Robert M.
Publicado em 2010

Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning...

Por Clayton, Anita H, Baker, Ross A, Sheehan, John J, Cain, Zachary J, Forbes, Robert A, Marler, Sabrina Vogel, Marcus, Ronald, Berman, Robert M, Thase, Michael E
Publicado em 2014